Stay updated on Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to include the study title 'A Multi-Center, Single Arm, Phase II Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: HCRN GI14-186' and the collaborators involved, specifically Merck Sharp & Dohme LLC. Additionally, the revision number has changed from v2.14.4 to v2.15.0.SummaryDifference47%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page.